B-HT 933 dihydrochloride facetamide C[S+](CC[C@H](N)C(O)=O)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2C(N)=NC=NC1=2

C[S+](CC[C@H](N)C(O)=O)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2C(N)=NC=NC1=2

9'-dihydrogenio-2'-(hydroxymethyl)-1'

137(33):10720-7

SID7970631 displays a cytotoxic effect not only on H295R/TR SF-1 cells

This is particularly relevant in the case of Trypanosoma species

B-HT 933 dihydrochloride facetamide C[S+](CC[C@H](N)C(O)=O)C[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2C(N)=NC=NC1=2IC50: 0. 44 M The contractile effects of adrenaline and noradrenaline may be mediated by both postjunctional 2 and 2 adrenoceptors on vascular smooth muscle. B HT 933 is a selective 2 adrenoceptor agonist. In vitro: B HT 933, a selective 2 adrenoceptor agonist, contracts human subcutaneous resistance arteries by a mechanism largely dependent on the influx of extracellular Ca2+, probably through voltage operated calcium channels. This action involves a